Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/02/2010US20100221305 Formulations for coated microprojections containing non-volatile counterions
09/02/2010US20100221299 Therapeutic stem cell nutrient composition and uses thereof
09/02/2010US20100221293 Controlled release formulations of opioid and nonopioid analgesics
09/02/2010US20100221281 High molecular weight polysaccharide that binds and inhibits virus
09/02/2010US20100221273 Treatment of viral infections
09/02/2010US20100221269 Synthetic lipid a derivative
09/02/2010US20100221266 Methods to regulate mirna processing by targeting lin-28
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221251 Compositions and Methods for Treatment of Cancer
09/02/2010US20100221247 Agents and methods for treatment of cancer
09/02/2010US20100221246 Methods and compositions for treating cancer
09/02/2010US20100221245 Topical skin care composition
09/02/2010US20100221242 Anti-viral griffithsin compounds, compositions and methods of use
09/02/2010US20100221229 Modulating bone growth in treating scoliosis
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221220 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of atp production
09/02/2010US20100221217 Therapeutic composition
09/02/2010US20100221216 Hepatitis c virus inhibitors
09/02/2010US20100221215 Linked dibenzimidazole derivatives
09/02/2010US20100221214 Linked dibenzimidazole derivatives
09/02/2010US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
09/02/2010US20100221211 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
09/02/2010US20100221201 Organosiloxanes Containing Ester Derivatives Of Ascorbic Acid
09/02/2010US20100221197 Antimicrobial agent and external preparation for skin containing the same
09/02/2010US20100221183 Peptides for treating and diagnosing cancers and methods for using the same
09/02/2010DE112004002032B4 Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung Concentricolid and its derivatives, method for preparing pharmaceutical compositions comprising the use of
09/02/2010DE102009009672A1 Regulatorische Nukleinsäure einer humanen Proteinase 3-Variante Regulatory nucleic acid of a human proteinase 3 variant
09/02/2010DE102008063992A1 Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung New aliphatic substituted pyrazolopyridines and their use
09/02/2010CA2759126A1 New compounds
09/02/2010CA2753964A1 Otic compositions useful for the treatment of infections of the internal and external ear in mammals
09/02/2010CA2753696A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/02/2010CA2753667A1 Amorphous salt of a macrocyclic inhibitor of hcv
09/02/2010CA2753652A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
09/02/2010CA2753641A1 Bendamustine cyclopolysaccharide compositions
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753599A1 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753562A1 Micrornas in never-smokers and related materials and methods
09/02/2010CA2753497A1 Topical foam composition
09/02/2010CA2753434A1 Soluble guanylate cyclase activators
09/02/2010CA2753426A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010CA2753421A1 Thienopyridine derivatives for the treatment and prevention of dengue virus infections
09/02/2010CA2753345A1 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
09/02/2010CA2753337A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010CA2753330A1 Uses of nk receptor antagonists
09/02/2010CA2753304A1 Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors
09/02/2010CA2753288A1 Oral care compositions for treating xerostomia
09/02/2010CA2753261A1 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
09/02/2010CA2753194A1 Iminosugars and methods of treating arenaviral infections
09/02/2010CA2753103A1 Equol-producing bacterium and use thereof
09/02/2010CA2752981A1 Indole derivatives as crth2 receptor antagonists
09/02/2010CA2752885A1 Jak kinase modulating quinazoline derivatives and methods of use thereof
09/02/2010CA2752813A1 Enhanced migraine treatments based on ghrelin mimetics
09/02/2010CA2752800A1 Prebiotic formulations and methods of use
09/02/2010CA2752485A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
09/02/2010CA2752003A1 Ceramide-analogous metabolites
09/02/2010CA2751854A1 Composition and drug delivery of bisphosphonates
09/02/2010CA2751343A1 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/02/2010CA2751328A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751327A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751322A1 Treatment of dyskinesia related disorders
09/02/2010CA2751321A1 Methods of administering (4ar, 1oar)-1-n-propyl-1,2,3,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751296A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751279A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751220A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
09/02/2010CA2751156A1 Visfatin therapeutic agents for the treatment of acne and other conditions
09/02/2010CA2750716A1 Pyrimidopyrimidoindazole derivative
09/02/2010CA2750699A1 Oxyindole derivatives with motilin receptor agonistic activity
09/02/2010CA2749702A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
09/02/2010CA2749403A1 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
09/02/2010CA2749236A1 Imidazo [1,2-a] pyridines as jnk modulators
09/02/2010CA2749212A1 Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker
09/01/2010EP2224010A1 Improved gene expression
09/01/2010EP2224005A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2224004A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223939A1 Transgenic mice used as models for human pathologies originating from stem cells
09/01/2010EP2223930A1 Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material
09/01/2010EP2223929A1 Gambogic glycoside derivatives and analogs, the preparation and the application thereof
09/01/2010EP2223927A2 Cyclic phosphonic acid based prodrugs of PMEA and its analogues
09/01/2010EP2223926A1 Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same
09/01/2010EP2223925A1 Kinase inhibitors
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223921A1 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223916A1 Morpholine derivatives as norepinephrine reuptake inhibitors
09/01/2010EP2223914A1 Tricyclic condensed pyrazole derivatives as CB1 inhibitors
09/01/2010EP2223913A1 Tricyclic pyrazole derivatives and microemulsions thereof as CB1- and/or CB2-inhibitors
09/01/2010EP2223703A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
09/01/2010EP2223695A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223694A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223693A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223692A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223691A1 Immunemodulating oligosaccharides
09/01/2010EP2223690A1 Pharmaceutical composition for ameliorating lower urinary tract symptom
09/01/2010EP2223689A1 Plastic container having cyclic polyolefin layer
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
1 ... 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 ... 7860